Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.120
+0.070 (6.67%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Fate Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-186.26-160.93-281.72-212.15-173.39
Upgrade
Depreciation & Amortization
18.9618.2813.765.853.09
Upgrade
Other Amortization
-7.22.6843.11
Upgrade
Loss (Gain) From Sale of Assets
0.94----
Upgrade
Asset Writedown & Restructuring Costs
14.74----
Upgrade
Loss (Gain) From Sale of Investments
-9.08-11.4-0.265.071.68
Upgrade
Stock-Based Compensation
41.543.4678.7354.3630.75
Upgrade
Other Operating Activities
-1.71-48.06-26.69-22.09108.31
Upgrade
Change in Accounts Receivable
-1.1136.65-29.8-3.16-5.52
Upgrade
Change in Accounts Payable
-1.66-28.9414.255.91-1.55
Upgrade
Change in Other Net Operating Assets
0.8211.47-19.16-0.65-5.7
Upgrade
Operating Cash Flow
-122.87-132.26-248.21-162.87-39.23
Upgrade
Capital Expenditures
-0.73-6.15-35.57-50.7-4.93
Upgrade
Investment in Securities
12.95118.82202.32-273.32-156.14
Upgrade
Investing Cash Flow
12.22112.67166.75-324.02-161.08
Upgrade
Issuance of Common Stock
74.830.099.21432.45282.35
Upgrade
Other Financing Activities
25.07--20.680.49
Upgrade
Financing Cash Flow
99.890.099.21453.13282.84
Upgrade
Net Cash Flow
-10.76-19.51-72.25-33.7682.53
Upgrade
Free Cash Flow
-123.6-138.42-283.77-213.57-44.16
Upgrade
Free Cash Flow Margin
-906.79%-217.87%-294.68%-382.43%-140.49%
Upgrade
Free Cash Flow Per Share
-1.09-1.41-2.93-2.25-0.54
Upgrade
Levered Free Cash Flow
-60.77-82.31-148.77-134.712.31
Upgrade
Unlevered Free Cash Flow
-60.77-82.31-148.77-134.712.31
Upgrade
Change in Net Working Capital
-1.7126.0215.6312.6-50.35
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q